By Delia Ann Deschaine and Megan Robertson U.S. cannabis businesses operate in an increasingly complex legal and regulatory environment. Many, if not most, of those complexities stem from marijuana’s classification in Schedule I of the federal Controlled Substances Act. That classification hinges on the determination that marijuana lacks a currently accepted medical use in treatment […]
Congressional Research Service (CRS)
Another Shot in the Arm for Legalization? New Laws Expanding Hemp Production Stepping Up the Discussion
What’s that? Hemp making a comeback? An illegal Substance 1 drug? Has the Drug Enforcement Administration gone soft on cannabis crime? No, that’s not likely. But when it comes to hemp, and medicinal CBD derived from hemp, all of which is treated as a Substance 1 drug by the DEA, recent legislature moves on hemp […]
